Evidence map›Paper›PMID 20554828›Full record

ArticleJournal of clinical microbiology2010

Detection and characterization of human Ureaplasma species and serovars by real-time PCR.

Li Xiao, John I Glass, Vanya Paralanov, Shibu Yooseph, Gail H Cassell, Lynn B Duffy, Ken B Waites

Abstract readComparative StudyEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed.

  1. Toll-like receptor variants and cervical Atopobium vaginae infection in women with pelvic inflammatory disease.American journal of reproductive immunology (New York, N.Y. : 1989) · 2018
    Trial
  2. Trial
  3. Trial
  4. Trial
  5. Hyperammonaemic encephalopathy and subsequent arthritis due to Ureaplasma urealyticum in a haematopoietic cell transplant recipient: a case report and literature review.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  6. InvasiveASM case reports · 2026
    Article
  7. Article
  8. Article
  9. Prostatic Abscess due toCase reports in infectious diseases · 2025
    Article
  10. Donor-derived Mycoplasma and Ureaplasma infections in lung transplant recipients: A prospective study of donor and recipient respiratory tract screening and recipient outcomes.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2024
    Article
  11. Article
  12. Risk factors, management, and clinical outcomes of invasive Mycoplasma and Ureaplasma infections after lung transplantation.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2024
    Article
  13. Article
  14. MYCO WELL D-ONE detection of Ureaplasma spp. and Mycoplasma hominis in sexual health patients in Wales.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2020
    Article
  15. Article
  16. Article
  17. GrpE Immunization Protects AgainstFrontiers in immunology · 2020
    Article
  18. Article
  19. PerinatalFrontiers in cellular and infection microbiology · 2019
    Article
  20. Frontiers in microbiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Li XiaoDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL 35249, USA.
John I Glass
Vanya Paralanov
Shibu Yooseph
Gail H Cassell
Lynn B Duffy
Ken B Waites

Funding

U UREALYTICUM ANTIGENR01AI028279 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CASSELL, GAIL H. · 1989 to 1998
–
NIAID NIH HHS AI 28279NIAID NIH HHS N01 AI030071PHS HHS R01209PHS HHS R01A1072577
6 · The paper itself

Abstract

We designed primers and probes for the detection and discrimination of Ureaplasma parvum and U. urealyticum and their 14 serovars by real-time PCR. The analytical sensitivity and specificity of the multiplex species-specific PCR were determined by testing corresponding American Type Culture Collection (ATCC) type strains, 47 other microbial species, and human genomic DNA. The limits of the multiplex PCR were 2.8 x 10(-2) CFU/microl PCR mixture for detecting U. parvum and 4.1 x 10(-2) CFU/microl PCR mixture for detecting U. urealyticum. Clinical specificity and sensitivity were proven by comparison with culture and traditional PCR. For the detection of any Ureaplasma species, the clinical sensitivity and specificity of real-time PCR were 96.9% and 79.0%, respectively, using culture as a reference. Multiplex real-time PCR was also more sensitive than traditional PCR in discriminating the two Ureaplasma species in culture-positive subcultures. Each of the 14 monoplex serovar-specific PCR assays was specific for the corresponding ATCC type strain serovar. This new species identification PCR is specific and sensitive in the detection of Ureaplasma species in clinical specimens, and the serovar-specific PCR assays are the first set of complete genotypic assays to differentiate all 14 known Ureaplasma serovars. These assays provide quick and reliable means for investigating the epidemiology and pathogenicity of ureaplasmas at the serovar level.

Indexed as

Bacteriological TechniquesDNA PrimersHumansOligonucleotide ProbesPolymerase Chain ReactionSensitivity and SpecificityUreaplasmaUreaplasma InfectionsDNA PrimersOligonucleotide Probes

Identifiers

PMID20554828
PMCPMC2916572

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.